April 29, 2018
2 min watch
Save
This article is more than 5 years old. Information may no longer be current.
VIDEO: Researcher discusses post hoc analysis of RADIANCE trial
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
HONOLULU — At the Association for Research in Vision and Ophthalmology meeting here, Carolyn Pan, MD, discusses post hoc analysis of the RADIANCE trial, in which safety and efficacy of Lucentis (ranibizumab, Genentech) was compared with verteporfin photodynamic therapy for treatment of myopic choroidal neovascularization.